Geode Capital Management’s Entera Bio ENTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTX
SL
SEIA
VF
GIA
Geode Capital Management's ENTX Position: Q2 2026 in Review
Geode Capital Management increased its Entera Bio (ENTX) stake by 42% in Q2 2026, buying an estimated $11K and bringing the position to 29,908 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4234.
Geode Capital Management first reported a position in ENTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $105K in Q2 2021. 15 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.
- Geode Capital Management held 29,908 shares of Entera Bio worth $52.9K as of Q2 2026.
- Geode Capital Management bought 8,772 Entera Bio shares in Q2 2026, an estimated $11K.
- Entera Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4234 holding.
- Geode Capital Management first reported a position in Entera Bio in Q2 2021 and has held it in 21 quarters since.
- Geode Capital Management's Entera Bio position peaked at $105K in Q2 2021.
- 15 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.